ClinicalTrials.Veeva

Menu

Rhythm Control of AF in Patients With Acute Stroke

Yonsei University logo

Yonsei University

Status

Unknown

Conditions

Atrial Fibrillation

Treatments

Procedure: Rhythm control
Procedure: Rate control

Study type

Interventional

Funder types

Other

Identifiers

NCT02285387
4-2014-0728

Details and patient eligibility

About

Prospective randomized (rhythm control or rate control) Objective of study

  1. To analyze long term outcome of patients with acute stroke with atrial fibrillation according to the rhythm control
  2. To analyze recurrence rate of atrial fibrillation or recurrence stroke in patients with acute stroke according to the rhythm control (by antiarrhythmic drug, cardioversion, catheter ablation)

Enrollment

300 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients with Atrial fibrillation (20~80 years old)
  2. patients with Acute stroke within 7 days
  3. LA diameter < 55mm
  4. patients possible to anticoagulation and anti arrhythmic drug
  5. NIHSS score ≤12

Exclusion criteria

  1. Hemorrhagic transformation

  2. Large cerebral lesion or cerebellar lesion (more than 1/3 of MCA area and 1/2 of ACA area, 1/2 of PCA area, 1/2 of cerebellar area)

  3. active internal bleeding

  4. Impossible to anticoagulation or anti arrhythmic drug

  5. Valvular AF (MA> GII, Mechanical valve, Mitral valve replacement)

  6. LV ejection fraction < 30%

  7. Structural cardiac disease

  8. Catheter ablation history for AF, Cardiac surgery

  9. Already prescribed anti arrhythmic drugs

  10. With severe medical disease

  11. Expected survival < 1year

  12. Severe alcoholics, drug addiction

  13. Contraindication to MRI 15. Pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

300 participants in 2 patient groups

Rhythm control group
Experimental group
Description:
1. Start AAD right after evaluating for LA size, EF, LA thrombus, and presence of CAD during anticoagulation 2. Cardioversion after 1 month 3. Rhythm FU schedule (2012 ACC/AHA/ESC guidelines) 4. If AF recur, RFCA
Treatment:
Procedure: Rhythm control
Rate control group
Active Comparator group
Description:
1. No AAD, just anticoagulation 2. HR control between 60\~110bpm (with beta blocker, calcium channel blocker, digoxin) 3. Without the treatment about antiarrhythmia and rhythm control, deification of rate control, the subject will be drop out for study.
Treatment:
Procedure: Rate control

Trial contacts and locations

1

Loading...

Central trial contact

Hui-Na Pak, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems